Cell Distribution Differences Of Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Patients With Kawasaki Disease

Seigo Korematsu, Yoko Ohta, Naotaka Tamai, Masahiro Takeguchi, Chika Goto, Hiroaki Miyahara, Tatsuya Kawano, Tatsuro Izumi

The Pediatric Infectious Disease Journal · 2012 · 24 citations · 6 references

Concepts

Abstract

The interaction of matrix metalloproteinase (MMP)-9 and tissue inhibitor of matrix metalloproteinase-1 has been implicated in the formation of coronary aneurysms in Kawasaki disease. MMP-9 and tissue inhibitor of matrix metalloproteinase-1 were distributed predominantly in the granulocytes and platelets, respectively, in patients with Kawasaki disease. The plasma values of MMP-9 correlated positively with the circulating neutrophil count. Inhibiting the activity of granulocytes and maintaining the platelet activity might prevent coronary aneurysms.

References

6